Find out what’s in the drug pipeline for autoimmune disease.
Drug Class Overview
FDA’s approval of the first generic version of Copaxone for treating patients with relapsing forms of multiple sclerosis has industry insiders contemplating the impact on the generics market as well as payer coverage strategies.
Drug shortages and manufacturer consolidation are leaving their imprint on the price of some generic drugs.
19 out of 20 patients who think they are allergic to penicillin are wrong and are costing 63% more
Drug shortages remain a serious problem for patient safety, according to newly published results from a survey of pharmacy directors.
Breakthrough Therapy Designation given to daclatasvir and asunaprevir